Label: LEVOCETIRIZINE DIHYDROCHLORIDE tablet, coated
-
NDC Code(s):
43598-735-04,
43598-735-22,
43598-735-30,
43598-735-35, view more43598-735-79, 43598-735-80, 43598-735-90, 43598-735-95
- Packager: Dr. Reddy's Laboratories Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated August 14, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Do not use
- if you have kidney disease
- if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine
When using this product
- drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- be careful when driving a motor vehicle or operating machinery
Stop use and ask doctor if
- you have trouble urinating or emptying your bladder
- an allergic reaction to this product occurs. Seek medical help right away.
-
Directions
adults 65 years of age and older - ask a doctor
adults and children 12-64 years of age - take 1 tablet (5 mg) once daily in the evening
- do not take more than 1 tablet (5 mg) in 24 hours
- 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
children 6-11 years of age - take 1/2 tablet (2.5 mg) once daily in the evening
- do not take more than 1/2 tablet (2.5 mg) in 24 hours
children under 6 years of age - do not use
consumers with kidney disease - do not use
- Other information
- Inactive ingredients
- Questions or comments?
- SPL UNCLASSIFIED SECTION
- Levocetirizine Dihydrochloride Tablets, USP 5 mg carton label
- Levocetirizine Dihydrochloride Tablets USP, 5 mg bottle label
-
INGREDIENTS AND APPEARANCE
LEVOCETIRIZINE DIHYDROCHLORIDE
levocetirizine dihydrochloride tablet, coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:43598-735 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength levocetirizine dihydrochloride (UNII: SOD6A38AGA) (levocetirizine - UNII:6U5EA9RT2O) levocetirizine dihydrochloride 5 mg Inactive Ingredients Ingredient Name Strength CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) MAGNESIUM STEARATE (UNII: 70097M6I30) HYPROMELLOSES (UNII: 3NXW29V3WO) TITANIUM DIOXIDE (UNII: 15FIX9V2JP) Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A) Product Characteristics Color white Score 2 pieces Shape OVAL Size 9mm Flavor Imprint Code L Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:43598-735-30 1 in 1 CARTON 08/20/2018 1 30 in 1 BOTTLE; Type 0: Not a Combination Product 2 NDC:43598-735-35 1 in 1 CARTON 03/12/2018 2 35 in 1 BOTTLE; Type 0: Not a Combination Product 3 NDC:43598-735-22 1 in 1 CARTON 03/12/2018 3 55 in 1 BOTTLE; Type 0: Not a Combination Product 4 NDC:43598-735-80 1 in 1 CARTON 03/12/2018 4 80 in 1 BOTTLE; Type 0: Not a Combination Product 5 NDC:43598-735-90 1 in 1 CARTON 08/20/2018 5 90 in 1 BOTTLE; Type 0: Not a Combination Product 6 NDC:43598-735-79 2 in 1 CARTON 04/17/2018 6 5 in 1 BLISTER PACK; Type 0: Not a Combination Product 7 NDC:43598-735-04 1 in 1 CARTON 02/15/2020 7 120 in 1 BOTTLE; Type 0: Not a Combination Product 8 NDC:43598-735-95 2 in 1 CARTON 10/27/2023 8 200 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA210375 03/12/2018 Labeler - Dr. Reddy's Laboratories Inc. (802315887) Establishment Name Address ID/FEI Business Operations Dr.Reddy's Laboratories Limited-FTO 3 918608162 analysis(43598-735) , manufacture(43598-735) Establishment Name Address ID/FEI Business Operations Reed-Lane, Inc. 001819879 pack(43598-735)